{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T14:53:24Z","timestamp":1783004004125,"version":"3.54.5"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T00:00:00Z","timestamp":1682035200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Cognitive impairment and affective disorders are common in patients with Cushing\u2019s syndrome (CS). In fact, as an effect of prolonged cortisol excess on the brain, patients with CS often have memory problems, concentration difficulties, impaired attention and executive function, that are not always reversible following successful treatment. Neuroimaging is essential for understanding the deleterious effects of hypercortisolism on the brain. In CS, structural alterations have been observed, including reduction of hippocampal volume, amygdala and the prefrontal cortex. The aim of this article is to summarize results from studies that have used functional magnetic resonance imaging (fMRI) to study functional brain alterations in patients with CS. In these studies, alterations in brain areas and networks essential for cognitive function, emotional processing, and executive function have been observed, both in patients with active CS as well as following treatment. Nevertheless, longitudinal studies with a comprehensive evaluation of functional brain alterations and neurocognitive evaluation are still needed to determine whether the apparent deleterious effects of hypercortisolism on the brain are reversible or not.<\/jats:p>","DOI":"10.3389\/fendo.2023.1163482","type":"journal-article","created":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T05:00:20Z","timestamp":1682053220000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Functional brain alterations in Cushing\u2019s syndrome"],"prefix":"10.3389","volume":"14","author":[{"given":"Eleni","family":"Papakokkinou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oskar","family":"Ragnarsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,4,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)68699-6","article-title":"Cushing\u2019s syndrome","volume":"367","author":"Newell-Price","year":"2006","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61375-1","article-title":"Cushing\u2019s syndrome","volume":"386","author":"Lacroix","year":"2015","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-11-0272","article-title":"The European registry on cushing\u2019s syndrome: 2-year experience. baseline demographic and clinical characteristics","volume":"165","author":"Valassi","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-02524","article-title":"Overall and disease-specific mortality in patients with cushing disease: A Swedish nationwide study","volume":"104","author":"Ragnarsson","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa291","article-title":"Excess morbidity persists in patients with Cushing\u2019s disease during long-term remission: a Swedish nationwide study","volume":"105","author":"Papakokkinou","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-3582","article-title":"Multisystem morbidity and mortality in cushing\u2019s syndrome: a cohort study","volume":"98","author":"Dekkers","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-14-0556","article-title":"Management of endocrine disease: mortality remains increased in Cushing\u2019s disease despite biochemical remission: A systematic review and meta-analysis","volume":"172","author":"van Haalen","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2021.101505","article-title":"Quality of life in cushing\u2019s syndrome","volume":"35","author":"Bride","year":"2021","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B9","article-title":"The basophil adenomas of the pituitary bodyand their clinical manifestations (Pituitary basophilism)","volume":"50","author":"Cushing","year":"1932","journal-title":"Bull Johns Hopkins Hosp"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3223(92)90079-f","article-title":"Hippocampal formation volume, memory dysfunction, and cortisol levels in patients with cushing\u2019s syndrome","volume":"32","author":"Starkman","year":"1992","journal-title":"Biol Psychiatry"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-2032","article-title":"Subtle cognitive impairments in patients with long-term cure of Cushing\u2019s disease","volume":"95","author":"Tiemensma","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-1945","article-title":"Long-term cognitive impairments and attentional deficits in patients with Cushing\u2019s disease and cortisol-producing adrenal adenoma in remission","volume":"97","author":"Ragnarsson","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/cen.12564","article-title":"Impaired decision-making and selective cortical frontal thinning in cushing\u2019s syndrome","volume":"81","author":"Crespo","year":"2014","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B14","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1530\/EJE-14-1101","article-title":"Mechanisms in endocrinology: Cushing\u2019s syndrome causes irreversible effects on the human brain: a systematic review of structural and functional magnetic resonance imaging studies","volume":"173","author":"Andela","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/nrn1683","article-title":"Stress and the brain: from adaptation to disease","volume":"6","author":"de Kloet","year":"2005","journal-title":"Nat Rev Neurosci"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1097\/MED.0000000000000414","article-title":"Structural brain abnormalities in cushing\u2019s syndrome","volume":"25","author":"Bauduin","year":"2018","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1111\/joim.13056","article-title":"Psychiatric and neurocognitive consequences of endogenous hypercortisolism","volume":"288","author":"Piasecka","year":"2020","journal-title":"J Intern Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e2507","DOI":"10.1002\/brb3.2507","article-title":"Altered hippocampal volume and functional connectivity in patients with Cushing\u2019s disease","volume":"12","author":"Li","year":"2022","journal-title":"Brain Behav"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2020.154432","article-title":"The chronic effect of cortisol on orchestrating cerebral blood flow and brain functional connectivity: Evidence from Cushing\u2019s disease","volume":"115","author":"Zhang","year":"2021","journal-title":"Metabolism"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s00234-019-02223-y","article-title":"Dysregulation of resting-state functional connectivity in patients with Cushing\u2019s disease","volume":"61","author":"Wang","year":"2019","journal-title":"Neuroradiology"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2020.12.146","article-title":"Disruption of rich-club connectivity in cushing disease","volume":"148","author":"Xu","year":"2021","journal-title":"World Neurosurg"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-19-0028","article-title":"Elevated resting-state connectivity in the medial temporal lobe and the prefrontal cortex among patients with cushing\u2019s syndrome in remission","volume":"180","author":"Stomby","year":"2019","journal-title":"Eur J Endocrinol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2017.05.010","article-title":"Decreased prefrontal functional brain response during memory testing in women with cushing\u2019s syndrome in remission","volume":"82","author":"Ragnarsson","year":"2017","journal-title":"Psychoneuroendocrinology"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1111\/cen.13277","article-title":"Altered spontaneous brain activity in Cushing\u2019s disease: a resting-state functional mri study","volume":"86","author":"Jiang","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2015.38","article-title":"Resting-state functional connectivity in patients with long-term remission of Cushing\u2019s disease","volume":"40","author":"van der Werff","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2015.05.001","article-title":"Altered neural processing of emotional faces in remitted Cushing\u2019s disease","volume":"59","author":"Bas-Hoogendam","year":"2015","journal-title":"Psychoneuroendocrinology"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2011.07.006","article-title":"Impact of chronic hypercortisolemia on affective processing","volume":"62","author":"Langenecker","year":"2012","journal-title":"Neuropharmacology"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1017\/S0954579408000564","article-title":"Altered amygdala and hippocampus function in adolescents with hypercortisolemia: a functional magnetic resonance imaging study of cushing syndrome","volume":"20","author":"Maheu","year":"2008","journal-title":"Dev Psychopathol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/s41583-021-00474-4","article-title":"The default mode network in cognition: a topographical perspective","volume":"22","author":"Smallwood","year":"2021","journal-title":"Nat Rev Neurosci"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-0512","article-title":"Increased prevalence of psychopathology and maladaptive personality traits after long-term cure of Cushing\u2019s disease","volume":"95","author":"Tiemensma","year":"2010","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1163482\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T05:00:22Z","timestamp":1682053222000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1163482\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,21]]},"references-count":30,"alternative-id":["10.3389\/fendo.2023.1163482"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1163482","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,21]]},"article-number":"1163482"}}